| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| cellular component organization or biogenesis | 20 out of 30 genes, 66.7% | 180 out of 533 genes, 33.8% | 0.0001558174 |
| cellular component organization | 19 out of 30 genes, 63.3% | 169 out of 533 genes, 31.7% | 0.0002433623 |
| cellular component movement | 8 out of 30 genes, 26.7% | 35 out of 533 genes, 6.6% | 0.0003173143 |
| myofibril assembly | 3 out of 30 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.0006224225 |
| actomyosin structure organization | 3 out of 30 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.0006224225 |
| ribosomal small subunit biogenesis | 3 out of 30 genes, 10.0% | 4 out of 533 genes, 0.8% | 0.0006224225 |
| regulation of biological quality | 11 out of 30 genes, 36.7% | 71 out of 533 genes, 13.3% | 0.0007447696 |
| regulation of actin filament polymerization | 4 out of 30 genes, 13.3% | 9 out of 533 genes, 1.7% | 0.0008498202 |
| regulation of actin polymerization or depolymerization | 4 out of 30 genes, 13.3% | 10 out of 533 genes, 1.9% | 0.00136073 |
| regulation of actin filament length | 4 out of 30 genes, 13.3% | 10 out of 533 genes, 1.9% | 0.00136073 |
| regulation of protein polymerization | 4 out of 30 genes, 13.3% | 10 out of 533 genes, 1.9% | 0.00136073 |
| muscle cell development | 3 out of 30 genes, 10.0% | 5 out of 533 genes, 0.9% | 0.001496672 |
| striated muscle cell development | 3 out of 30 genes, 10.0% | 5 out of 533 genes, 0.9% | 0.001496672 |
| regulation of actin cytoskeleton organization | 4 out of 30 genes, 13.3% | 11 out of 533 genes, 2.1% | 0.002054316 |
| regulation of actin filament-based process | 4 out of 30 genes, 13.3% | 11 out of 533 genes, 2.1% | 0.002054316 |
| negative regulation of actin filament depolymerization | 3 out of 30 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.002879244 |
| negative regulation of actin filament polymerization | 3 out of 30 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.002879244 |
| erythrocyte homeostasis | 3 out of 30 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.002879244 |
| actin filament capping | 3 out of 30 genes, 10.0% | 6 out of 533 genes, 1.1% | 0.002879244 |
| regulation of cellular component size | 4 out of 30 genes, 13.3% | 12 out of 533 genes, 2.3% | 0.002960496 |
| striated muscle contraction | 2 out of 30 genes, 6.7% | 2 out of 533 genes, 0.4% | 0.003068177 |
| ruffle organization | 2 out of 30 genes, 6.7% | 2 out of 533 genes, 0.4% | 0.003068177 |
| sarcomere organization | 2 out of 30 genes, 6.7% | 2 out of 533 genes, 0.4% | 0.003068177 |
| cardiac muscle contraction | 2 out of 30 genes, 6.7% | 2 out of 533 genes, 0.4% | 0.003068177 |
| regulation of anatomical structure size | 4 out of 30 genes, 13.3% | 13 out of 533 genes, 2.4% | 0.00410844 |
| homeostatic process | 6 out of 30 genes, 20.0% | 30 out of 533 genes, 5.6% | 0.004343849 |
| cellular component assembly involved in morphogenesis | 3 out of 30 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.004846852 |
| regulation of actin filament depolymerization | 3 out of 30 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.004846852 |
| negative regulation of protein polymerization | 3 out of 30 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.004846852 |
| negative regulation of protein complex disassembly | 3 out of 30 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.004846852 |
| striated muscle cell differentiation | 3 out of 30 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.004846852 |
| negative regulation of protein depolymerization | 3 out of 30 genes, 10.0% | 7 out of 533 genes, 1.3% | 0.004846852 |
| cellular component biogenesis | 11 out of 30 genes, 36.7% | 89 out of 533 genes, 16.7% | 0.005387556 |
| regulation of protein complex assembly | 4 out of 30 genes, 13.3% | 15 out of 533 genes, 2.8% | 0.007240117 |
| negative regulation of cellular component organization | 4 out of 30 genes, 13.3% | 15 out of 533 genes, 2.8% | 0.007240117 |
| negative regulation of protein complex assembly | 3 out of 30 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.007460105 |
| homeostasis of number of cells | 3 out of 30 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.007460105 |
| negative regulation of cytoskeleton organization | 3 out of 30 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.007460105 |
| regulation of protein depolymerization | 3 out of 30 genes, 10.0% | 8 out of 533 genes, 1.5% | 0.007460105 |
| regulation of heart contraction | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| fertilization | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| muscle filament sliding | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| erythrocyte differentiation | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| muscle organ morphogenesis | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| cardiac muscle tissue development | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| cardiac muscle tissue morphogenesis | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| muscle tissue morphogenesis | 2 out of 30 genes, 6.7% | 3 out of 533 genes, 0.6% | 0.008880957 |
| cell motility | 4 out of 30 genes, 13.3% | 16 out of 533 genes, 3.0% | 0.00927504 |
| regulation of cytoskeleton organization | 4 out of 30 genes, 13.3% | 16 out of 533 genes, 3.0% | 0.00927504 |
| localization of cell | 4 out of 30 genes, 13.3% | 16 out of 533 genes, 3.0% | 0.00927504 |
| cellular component morphogenesis | 5 out of 30 genes, 16.7% | 25 out of 533 genes, 4.7% | 0.009595214 |
| negative regulation of organelle organization | 3 out of 30 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.01076525 |
| cell junction organization | 3 out of 30 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.01076525 |
| muscle cell differentiation | 3 out of 30 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.01076525 |
| regulation of protein complex disassembly | 3 out of 30 genes, 10.0% | 9 out of 533 genes, 1.7% | 0.01076525 |
| regulation of cellular component biogenesis | 4 out of 30 genes, 13.3% | 17 out of 533 genes, 3.2% | 0.01165361 |
| cell projection organization | 5 out of 30 genes, 16.7% | 27 out of 533 genes, 5.1% | 0.01344553 |
| cellular developmental process | 8 out of 30 genes, 26.7% | 61 out of 533 genes, 11.4% | 0.01412845 |
| cellular component assembly | 9 out of 30 genes, 30.0% | 74 out of 533 genes, 13.9% | 0.01464056 |
| single-organism cellular process | 24 out of 30 genes, 80.0% | 320 out of 533 genes, 60.0% | 0.01497085 |
| single-organism process | 25 out of 30 genes, 83.3% | 341 out of 533 genes, 64.0% | 0.01535057 |
| locomotion | 5 out of 30 genes, 16.7% | 28 out of 533 genes, 5.3% | 0.01571883 |
| heart morphogenesis | 2 out of 30 genes, 6.7% | 4 out of 533 genes, 0.8% | 0.01713949 |
| circulatory system process | 2 out of 30 genes, 6.7% | 4 out of 533 genes, 0.8% | 0.01713949 |
| heart process | 2 out of 30 genes, 6.7% | 4 out of 533 genes, 0.8% | 0.01713949 |
| blood circulation | 2 out of 30 genes, 6.7% | 4 out of 533 genes, 0.8% | 0.01713949 |
| actin-myosin filament sliding | 2 out of 30 genes, 6.7% | 4 out of 533 genes, 0.8% | 0.01713949 |
| positive regulation of lymphocyte activation | 2 out of 30 genes, 6.7% | 4 out of 533 genes, 0.8% | 0.01713949 |
| heart contraction | 2 out of 30 genes, 6.7% | 4 out of 533 genes, 0.8% | 0.01713949 |
| actin-mediated cell contraction | 2 out of 30 genes, 6.7% | 4 out of 533 genes, 0.8% | 0.01713949 |
| system development | 7 out of 30 genes, 23.3% | 51 out of 533 genes, 9.6% | 0.01752134 |
| actin filament-based process | 4 out of 30 genes, 13.3% | 19 out of 533 genes, 3.6% | 0.01752145 |
| rRNA processing | 3 out of 30 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.01957379 |
| rRNA metabolic process | 3 out of 30 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.01957379 |
| muscle structure development | 3 out of 30 genes, 10.0% | 11 out of 533 genes, 2.1% | 0.01957379 |
| organ development | 5 out of 30 genes, 16.7% | 31 out of 533 genes, 5.8% | 0.02406624 |
| organelle organization | 9 out of 30 genes, 30.0% | 80 out of 533 genes, 15.0% | 0.02415936 |
| positive regulation of leukocyte activation | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| muscle system process | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| 'de novo' protein folding | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| muscle contraction | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| striated muscle tissue development | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| myeloid cell differentiation | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| positive regulation of cell activation | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| 'de novo' posttranslational protein folding | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| positive regulation of cytoskeleton organization | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| muscle tissue development | 2 out of 30 genes, 6.7% | 5 out of 533 genes, 0.9% | 0.02756804 |
| cell differentiation | 7 out of 30 genes, 23.3% | 56 out of 533 genes, 10.5% | 0.02864137 |
| regulation of organelle organization | 4 out of 30 genes, 13.3% | 22 out of 533 genes, 4.1% | 0.02933758 |
| organ morphogenesis | 3 out of 30 genes, 10.0% | 13 out of 533 genes, 2.4% | 0.0314125 |
| response to wounding | 4 out of 30 genes, 13.3% | 23 out of 533 genes, 4.3% | 0.03412665 |
| immune system development | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| muscle organ development | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| actin filament-based movement | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| hemopoiesis | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| cell-substrate adhesion | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| cell-cell junction organization | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| hematopoietic or lymphoid organ development | 2 out of 30 genes, 6.7% | 6 out of 533 genes, 1.1% | 0.03991243 |
| anatomical structure development | 8 out of 30 genes, 26.7% | 74 out of 533 genes, 13.9% | 0.04270911 |
| cell migration | 3 out of 30 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.04628048 |
| actin cytoskeleton organization | 3 out of 30 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.04628048 |
| regulation of cell migration | 3 out of 30 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.04628048 |
| ncRNA processing | 3 out of 30 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.04628048 |
| regulation of locomotion | 3 out of 30 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.04628048 |
| wound healing | 3 out of 30 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.04628048 |
| regulation of cell motility | 3 out of 30 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.04628048 |
| regulation of developmental process | 5 out of 30 genes, 16.7% | 37 out of 533 genes, 6.9% | 0.04842287 |
| inflammatory response | 2 out of 30 genes, 6.7% | 7 out of 533 genes, 1.3% | 0.05393867 |
| response to metal ion | 2 out of 30 genes, 6.7% | 7 out of 533 genes, 1.3% | 0.05393867 |
| regulation of lipid metabolic process | 2 out of 30 genes, 6.7% | 7 out of 533 genes, 1.3% | 0.05393867 |
| cell junction assembly | 2 out of 30 genes, 6.7% | 7 out of 533 genes, 1.3% | 0.05393867 |
| regulation of lymphocyte activation | 2 out of 30 genes, 6.7% | 7 out of 533 genes, 1.3% | 0.05393867 |
| protein polymerization | 2 out of 30 genes, 6.7% | 7 out of 533 genes, 1.3% | 0.05393867 |
| regulation of cellular component movement | 3 out of 30 genes, 10.0% | 16 out of 533 genes, 3.0% | 0.0548202 |
| anatomical structure morphogenesis | 5 out of 30 genes, 16.7% | 39 out of 533 genes, 7.3% | 0.05898607 |
| single-organism developmental process | 7 out of 30 genes, 23.3% | 65 out of 533 genes, 12.2% | 0.05953574 |
| tissue development | 3 out of 30 genes, 10.0% | 17 out of 533 genes, 3.2% | 0.06407018 |
| regulation of leukocyte activation | 2 out of 30 genes, 6.7% | 8 out of 533 genes, 1.5% | 0.06943152 |
| regulation of cell activation | 2 out of 30 genes, 6.7% | 8 out of 533 genes, 1.5% | 0.06943152 |
| cell development | 4 out of 30 genes, 13.3% | 29 out of 533 genes, 5.4% | 0.07211289 |
| macromolecular complex subunit organization | 8 out of 30 genes, 26.7% | 82 out of 533 genes, 15.4% | 0.07284174 |
| protein folding | 3 out of 30 genes, 10.0% | 18 out of 533 genes, 3.4% | 0.07400495 |
| ribosome biogenesis | 3 out of 30 genes, 10.0% | 18 out of 533 genes, 3.4% | 0.07400495 |
| cellular macromolecular complex assembly | 4 out of 30 genes, 13.3% | 30 out of 533 genes, 5.6% | 0.0799735 |
| heart development | 2 out of 30 genes, 6.7% | 9 out of 533 genes, 1.7% | 0.08619331 |
| cell projection assembly | 2 out of 30 genes, 6.7% | 9 out of 533 genes, 1.7% | 0.08619331 |
| cellular protein complex assembly | 2 out of 30 genes, 6.7% | 9 out of 533 genes, 1.7% | 0.08619331 |
| tissue morphogenesis | 2 out of 30 genes, 6.7% | 9 out of 533 genes, 1.7% | 0.08619331 |
| multicellular organismal development | 7 out of 30 genes, 23.3% | 71 out of 533 genes, 13.3% | 0.08892932 |
| cell part morphogenesis | 3 out of 30 genes, 10.0% | 20 out of 533 genes, 3.8% | 0.09581046 |
| anatomical structure formation involved in morphogenesis | 3 out of 30 genes, 10.0% | 20 out of 533 genes, 3.8% | 0.09581046 |
| cell projection morphogenesis | 3 out of 30 genes, 10.0% | 20 out of 533 genes, 3.8% | 0.09581046 |
| DNA packaging | 2 out of 30 genes, 6.7% | 10 out of 533 genes, 1.9% | 0.1040427 |
| positive regulation of organelle organization | 2 out of 30 genes, 6.7% | 10 out of 533 genes, 1.9% | 0.1040427 |
| response to abiotic stimulus | 3 out of 30 genes, 10.0% | 21 out of 533 genes, 3.9% | 0.1076156 |
| ncRNA metabolic process | 3 out of 30 genes, 10.0% | 21 out of 533 genes, 3.9% | 0.1076156 |
| protein complex subunit organization | 6 out of 30 genes, 20.0% | 61 out of 533 genes, 11.4% | 0.1149178 |
| cell morphogenesis | 3 out of 30 genes, 10.0% | 22 out of 533 genes, 4.1% | 0.1199752 |
| neuron differentiation | 3 out of 30 genes, 10.0% | 22 out of 533 genes, 4.1% | 0.1199752 |
| regulation of cytokine production | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| positive regulation of immune system process | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| sexual reproduction | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| extracellular matrix organization | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| extracellular structure organization | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| DNA conformation change | 2 out of 30 genes, 6.7% | 11 out of 533 genes, 2.1% | 0.1228136 |
| regulation of multicellular organismal process | 5 out of 30 genes, 16.7% | 49 out of 533 genes, 9.2% | 0.1304182 |
| developmental process | 8 out of 30 genes, 26.7% | 94 out of 533 genes, 17.6% | 0.1388703 |
| macromolecular complex assembly | 5 out of 30 genes, 16.7% | 50 out of 533 genes, 9.4% | 0.1391821 |
| blood coagulation | 2 out of 30 genes, 6.7% | 12 out of 533 genes, 2.3% | 0.142354 |
| hemostasis | 2 out of 30 genes, 6.7% | 12 out of 533 genes, 2.3% | 0.142354 |
| response to inorganic substance | 2 out of 30 genes, 6.7% | 12 out of 533 genes, 2.3% | 0.142354 |
| coagulation | 2 out of 30 genes, 6.7% | 12 out of 533 genes, 2.3% | 0.142354 |
| cellular process | 28 out of 30 genes, 93.3% | 453 out of 533 genes, 85.0% | 0.1434426 |
| response to external stimulus | 3 out of 30 genes, 10.0% | 24 out of 533 genes, 4.5% | 0.1462096 |
| translation | 5 out of 30 genes, 16.7% | 51 out of 533 genes, 9.6% | 0.1482151 |
| immune system process | 4 out of 30 genes, 13.3% | 38 out of 533 genes, 7.1% | 0.1570868 |
| regulation of localization | 5 out of 30 genes, 16.7% | 52 out of 533 genes, 9.8% | 0.1575084 |
| translational elongation | 3 out of 30 genes, 10.0% | 25 out of 533 genes, 4.7% | 0.1600079 |
| ribonucleoprotein complex biogenesis | 3 out of 30 genes, 10.0% | 25 out of 533 genes, 4.7% | 0.1600079 |
| microtubule-based movement | 2 out of 30 genes, 6.7% | 13 out of 533 genes, 2.4% | 0.1625252 |
| single organism reproductive process | 2 out of 30 genes, 6.7% | 13 out of 533 genes, 2.4% | 0.1625252 |
| negative regulation of cellular process | 8 out of 30 genes, 26.7% | 99 out of 533 genes, 18.6% | 0.1737063 |
| regulation of immune system process | 3 out of 30 genes, 10.0% | 26 out of 533 genes, 4.9% | 0.174209 |
| axon guidance | 2 out of 30 genes, 6.7% | 14 out of 533 genes, 2.6% | 0.1832006 |
| cellular lipid metabolic process | 2 out of 30 genes, 6.7% | 14 out of 533 genes, 2.6% | 0.1832006 |
| small molecule biosynthetic process | 2 out of 30 genes, 6.7% | 14 out of 533 genes, 2.6% | 0.1832006 |
| regulation of body fluid levels | 2 out of 30 genes, 6.7% | 14 out of 533 genes, 2.6% | 0.1832006 |
| negative regulation of developmental process | 2 out of 30 genes, 6.7% | 14 out of 533 genes, 2.6% | 0.1832006 |
| cardiovascular system development | 2 out of 30 genes, 6.7% | 14 out of 533 genes, 2.6% | 0.1832006 |
| circulatory system development | 2 out of 30 genes, 6.7% | 14 out of 533 genes, 2.6% | 0.1832006 |
| reproduction | 5 out of 30 genes, 16.7% | 55 out of 533 genes, 10.3% | 0.1868561 |
| neurogenesis | 3 out of 30 genes, 10.0% | 27 out of 533 genes, 5.1% | 0.1887742 |
| generation of neurons | 3 out of 30 genes, 10.0% | 27 out of 533 genes, 5.1% | 0.1887742 |
| chromosome organization | 3 out of 30 genes, 10.0% | 27 out of 533 genes, 5.1% | 0.1887742 |
| organic substance biosynthetic process | 9 out of 30 genes, 30.0% | 118 out of 533 genes, 22.1% | 0.196906 |
| regulation of phosphate metabolic process | 4 out of 30 genes, 13.3% | 42 out of 533 genes, 7.9% | 0.2036302 |
| regulation of phosphorus metabolic process | 4 out of 30 genes, 13.3% | 42 out of 533 genes, 7.9% | 0.2036302 |
| cytoskeleton organization | 3 out of 30 genes, 10.0% | 28 out of 533 genes, 5.3% | 0.2036653 |
| cellular component disassembly | 3 out of 30 genes, 10.0% | 28 out of 533 genes, 5.3% | 0.2036653 |
| regulation of phosphorylation | 3 out of 30 genes, 10.0% | 28 out of 533 genes, 5.3% | 0.2036653 |
| M phase | 2 out of 30 genes, 6.7% | 15 out of 533 genes, 2.8% | 0.2042652 |
| positive regulation of kinase activity | 2 out of 30 genes, 6.7% | 15 out of 533 genes, 2.8% | 0.2042652 |
| regulation of system process | 2 out of 30 genes, 6.7% | 15 out of 533 genes, 2.8% | 0.2042652 |
| single-organism biosynthetic process | 2 out of 30 genes, 6.7% | 15 out of 533 genes, 2.8% | 0.2042652 |
| positive regulation of transferase activity | 2 out of 30 genes, 6.7% | 15 out of 533 genes, 2.8% | 0.2042652 |
| single-multicellular organism process | 7 out of 30 genes, 23.3% | 88 out of 533 genes, 16.5% | 0.2108938 |
| biosynthetic process | 9 out of 30 genes, 30.0% | 120 out of 533 genes, 22.5% | 0.2119283 |
| organic acid metabolic process | 3 out of 30 genes, 10.0% | 29 out of 533 genes, 5.4% | 0.2188444 |
| protein complex assembly | 3 out of 30 genes, 10.0% | 29 out of 533 genes, 5.4% | 0.2188444 |
| carboxylic acid metabolic process | 3 out of 30 genes, 10.0% | 29 out of 533 genes, 5.4% | 0.2188444 |
| oxoacid metabolic process | 3 out of 30 genes, 10.0% | 29 out of 533 genes, 5.4% | 0.2188444 |
| defense response | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| axonogenesis | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| embryo development | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| chromatin modification | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| regulation of anatomical structure morphogenesis | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| neuron projection development | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| cell morphogenesis involved in neuron differentiation | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| neuron projection morphogenesis | 2 out of 30 genes, 6.7% | 16 out of 533 genes, 3.0% | 0.2256145 |
| cell adhesion | 3 out of 30 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.2342745 |
| biological adhesion | 3 out of 30 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.2342745 |
| protein complex biogenesis | 3 out of 30 genes, 10.0% | 30 out of 533 genes, 5.6% | 0.2342745 |
| negative regulation of biological process | 8 out of 30 genes, 26.7% | 107 out of 533 genes, 20.1% | 0.2373977 |
| response to stress | 6 out of 30 genes, 20.0% | 76 out of 533 genes, 14.3% | 0.2452483 |
| chemotaxis | 2 out of 30 genes, 6.7% | 17 out of 533 genes, 3.2% | 0.2471538 |
| taxis | 2 out of 30 genes, 6.7% | 17 out of 533 genes, 3.2% | 0.2471538 |
| chemical homeostasis | 2 out of 30 genes, 6.7% | 17 out of 533 genes, 3.2% | 0.2471538 |
| biological regulation | 18 out of 30 genes, 60.0% | 279 out of 533 genes, 52.3% | 0.2503052 |
| regulation of cellular component organization | 4 out of 30 genes, 13.3% | 46 out of 533 genes, 8.6% | 0.2540028 |
| multicellular organismal process | 7 out of 30 genes, 23.3% | 93 out of 533 genes, 17.4% | 0.256101 |
| cellular process involved in reproduction | 3 out of 30 genes, 10.0% | 32 out of 533 genes, 6.0% | 0.2657436 |
| cell morphogenesis involved in differentiation | 2 out of 30 genes, 6.7% | 18 out of 533 genes, 3.4% | 0.2687974 |
| positive regulation of cellular component organization | 2 out of 30 genes, 6.7% | 18 out of 533 genes, 3.4% | 0.2687974 |
| macromolecule biosynthetic process | 6 out of 30 genes, 20.0% | 79 out of 533 genes, 14.8% | 0.2759541 |
| cellular macromolecule biosynthetic process | 6 out of 30 genes, 20.0% | 79 out of 533 genes, 14.8% | 0.2759541 |
| positive regulation of protein phosphorylation | 2 out of 30 genes, 6.7% | 19 out of 533 genes, 3.6% | 0.2904682 |
| neuron development | 2 out of 30 genes, 6.7% | 19 out of 533 genes, 3.6% | 0.2904682 |
| positive regulation of catalytic activity | 3 out of 30 genes, 10.0% | 34 out of 533 genes, 6.4% | 0.2977951 |
| cellular biosynthetic process | 8 out of 30 genes, 26.7% | 114 out of 533 genes, 21.4% | 0.2997066 |
| reproductive process | 4 out of 30 genes, 13.3% | 50 out of 533 genes, 9.4% | 0.3069865 |
| system process | 2 out of 30 genes, 6.7% | 20 out of 533 genes, 3.8% | 0.3120968 |
| cellular membrane organization | 2 out of 30 genes, 6.7% | 20 out of 533 genes, 3.8% | 0.3120968 |
| positive regulation of phosphorylation | 2 out of 30 genes, 6.7% | 20 out of 533 genes, 3.8% | 0.3120968 |
| membrane organization | 2 out of 30 genes, 6.7% | 20 out of 533 genes, 3.8% | 0.3120968 |
| nervous system development | 3 out of 30 genes, 10.0% | 36 out of 533 genes, 6.8% | 0.3301702 |
| translational termination | 2 out of 30 genes, 6.7% | 21 out of 533 genes, 3.9% | 0.3336212 |
| lipid metabolic process | 2 out of 30 genes, 6.7% | 21 out of 533 genes, 3.9% | 0.3336212 |
| microtubule-based process | 2 out of 30 genes, 6.7% | 21 out of 533 genes, 3.9% | 0.3336212 |
| viral genome expression | 2 out of 30 genes, 6.7% | 21 out of 533 genes, 3.9% | 0.3336212 |
| viral transcription | 2 out of 30 genes, 6.7% | 21 out of 533 genes, 3.9% | 0.3336212 |
| regulation of catalytic activity | 4 out of 30 genes, 13.3% | 52 out of 533 genes, 9.8% | 0.3340816 |
| chromatin organization | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| positive regulation of phosphorus metabolic process | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| protein complex disassembly | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| regulation of kinase activity | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| cellular protein complex disassembly | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| positive regulation of phosphate metabolic process | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| regulation of transferase activity | 2 out of 30 genes, 6.7% | 22 out of 533 genes, 4.1% | 0.3549858 |
| viral infectious cycle | 2 out of 30 genes, 6.7% | 23 out of 533 genes, 4.3% | 0.3761413 |
| cell cycle phase | 2 out of 30 genes, 6.7% | 23 out of 533 genes, 4.3% | 0.3761413 |
| macromolecular complex disassembly | 2 out of 30 genes, 6.7% | 23 out of 533 genes, 4.3% | 0.3761413 |
| regulation of multicellular organismal development | 2 out of 30 genes, 6.7% | 23 out of 533 genes, 4.3% | 0.3761413 |
| protein metabolic process | 10 out of 30 genes, 33.3% | 158 out of 533 genes, 29.6% | 0.3925483 |
| mitotic cell cycle | 2 out of 30 genes, 6.7% | 24 out of 533 genes, 4.5% | 0.3970442 |
| cotranslational protein targeting to membrane | 2 out of 30 genes, 6.7% | 24 out of 533 genes, 4.5% | 0.3970442 |
| SRP-dependent cotranslational protein targeting to membrane | 2 out of 30 genes, 6.7% | 24 out of 533 genes, 4.5% | 0.3970442 |
| protein targeting to ER | 2 out of 30 genes, 6.7% | 24 out of 533 genes, 4.5% | 0.3970442 |
| regulation of cell differentiation | 2 out of 30 genes, 6.7% | 24 out of 533 genes, 4.5% | 0.3970442 |
| protein localization to endoplasmic reticulum | 2 out of 30 genes, 6.7% | 24 out of 533 genes, 4.5% | 0.3970442 |
| establishment of protein localization to endoplasmic reticulum | 2 out of 30 genes, 6.7% | 24 out of 533 genes, 4.5% | 0.3970442 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2 out of 30 genes, 6.7% | 25 out of 533 genes, 4.7% | 0.417656 |
| regulation of protein phosphorylation | 2 out of 30 genes, 6.7% | 25 out of 533 genes, 4.7% | 0.417656 |
| regulation of cell cycle | 2 out of 30 genes, 6.7% | 25 out of 533 genes, 4.7% | 0.417656 |
| viral reproduction | 3 out of 30 genes, 10.0% | 42 out of 533 genes, 7.9% | 0.4269711 |
| multi-organism cellular process | 3 out of 30 genes, 10.0% | 42 out of 533 genes, 7.9% | 0.4269711 |
| protein targeting to membrane | 2 out of 30 genes, 6.7% | 26 out of 533 genes, 4.9% | 0.4379433 |
| regulation of hydrolase activity | 2 out of 30 genes, 6.7% | 26 out of 533 genes, 4.9% | 0.4379433 |
| single-organism transport | 6 out of 30 genes, 20.0% | 94 out of 533 genes, 17.6% | 0.4401749 |
| positive regulation of molecular function | 3 out of 30 genes, 10.0% | 43 out of 533 genes, 8.1% | 0.4428005 |
| nuclear-transcribed mRNA catabolic process | 2 out of 30 genes, 6.7% | 27 out of 533 genes, 5.1% | 0.4578768 |
| negative regulation of RNA metabolic process | 2 out of 30 genes, 6.7% | 27 out of 533 genes, 5.1% | 0.4578768 |
| establishment of protein localization to organelle | 2 out of 30 genes, 6.7% | 27 out of 533 genes, 5.1% | 0.4578768 |
| regulation of response to stress | 2 out of 30 genes, 6.7% | 27 out of 533 genes, 5.1% | 0.4578768 |
| response to oxygen-containing compound | 2 out of 30 genes, 6.7% | 27 out of 533 genes, 5.1% | 0.4578768 |
| localization | 9 out of 30 genes, 30.0% | 148 out of 533 genes, 27.8% | 0.4605764 |
| RNA catabolic process | 2 out of 30 genes, 6.7% | 28 out of 533 genes, 5.3% | 0.4774316 |
| mRNA catabolic process | 2 out of 30 genes, 6.7% | 28 out of 533 genes, 5.3% | 0.4774316 |
| translational initiation | 2 out of 30 genes, 6.7% | 28 out of 533 genes, 5.3% | 0.4774316 |
| positive regulation of protein modification process | 2 out of 30 genes, 6.7% | 28 out of 533 genes, 5.3% | 0.4774316 |
| negative regulation of nucleobase-containing compound metabolic process | 2 out of 30 genes, 6.7% | 30 out of 533 genes, 5.6% | 0.5153227 |
| negative regulation of nitrogen compound metabolic process | 2 out of 30 genes, 6.7% | 30 out of 533 genes, 5.6% | 0.5153227 |
| nucleobase-containing compound catabolic process | 4 out of 30 genes, 13.3% | 66 out of 533 genes, 12.4% | 0.5226169 |
| regulation of molecular function | 4 out of 30 genes, 13.3% | 66 out of 533 genes, 12.4% | 0.5226169 |
| RNA processing | 3 out of 30 genes, 10.0% | 49 out of 533 genes, 9.2% | 0.5342061 |
| aromatic compound catabolic process | 4 out of 30 genes, 13.3% | 67 out of 533 genes, 12.6% | 0.5354209 |
| positive regulation of signal transduction | 2 out of 30 genes, 6.7% | 32 out of 533 genes, 6.0% | 0.5514852 |
| positive regulation of cell communication | 2 out of 30 genes, 6.7% | 32 out of 533 genes, 6.0% | 0.5514852 |
| positive regulation of signaling | 2 out of 30 genes, 6.7% | 32 out of 533 genes, 6.0% | 0.5514852 |
| positive regulation of cellular protein metabolic process | 2 out of 30 genes, 6.7% | 32 out of 533 genes, 6.0% | 0.5514852 |
| macromolecule metabolic process | 13 out of 30 genes, 43.3% | 229 out of 533 genes, 43.0% | 0.5554964 |
| purine nucleoside catabolic process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| nucleoside triphosphate catabolic process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| purine nucleoside triphosphate catabolic process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| nucleoside catabolic process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| ribonucleoside triphosphate catabolic process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| purine ribonucleoside triphosphate catabolic process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| negative regulation of gene expression | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| cell cycle process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| ribonucleoside catabolic process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| purine ribonucleoside catabolic process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| glycosyl compound catabolic process | 2 out of 30 genes, 6.7% | 33 out of 533 genes, 6.2% | 0.5688899 |
| positive regulation of cellular process | 6 out of 30 genes, 20.0% | 106 out of 533 genes, 19.9% | 0.5704422 |
| cellular nitrogen compound catabolic process | 4 out of 30 genes, 13.3% | 70 out of 533 genes, 13.1% | 0.5729133 |
| heterocycle catabolic process | 4 out of 30 genes, 13.3% | 70 out of 533 genes, 13.1% | 0.5729133 |
| organic cyclic compound catabolic process | 4 out of 30 genes, 13.3% | 70 out of 533 genes, 13.1% | 0.5729133 |
| negative regulation of macromolecule metabolic process | 3 out of 30 genes, 10.0% | 52 out of 533 genes, 9.8% | 0.5769864 |
| cellular protein metabolic process | 8 out of 30 genes, 26.7% | 143 out of 533 genes, 26.8% | 0.5807718 |
| gene expression | 6 out of 30 genes, 20.0% | 107 out of 533 genes, 20.1% | 0.580799 |
| purine nucleotide catabolic process | 2 out of 30 genes, 6.7% | 34 out of 533 genes, 6.4% | 0.5858333 |
| DNA metabolic process | 2 out of 30 genes, 6.7% | 34 out of 533 genes, 6.4% | 0.5858333 |
| purine ribonucleotide catabolic process | 2 out of 30 genes, 6.7% | 34 out of 533 genes, 6.4% | 0.5858333 |
| nucleotide catabolic process | 2 out of 30 genes, 6.7% | 34 out of 533 genes, 6.4% | 0.5858333 |
| ribonucleotide catabolic process | 2 out of 30 genes, 6.7% | 34 out of 533 genes, 6.4% | 0.5858333 |
| organophosphate catabolic process | 2 out of 30 genes, 6.7% | 34 out of 533 genes, 6.4% | 0.5858333 |
| purine-containing compound catabolic process | 2 out of 30 genes, 6.7% | 34 out of 533 genes, 6.4% | 0.5858333 |
| nucleoside phosphate catabolic process | 2 out of 30 genes, 6.7% | 34 out of 533 genes, 6.4% | 0.5858333 |
| negative regulation of metabolic process | 3 out of 30 genes, 10.0% | 53 out of 533 genes, 9.9% | 0.5907426 |
| primary metabolic process | 17 out of 30 genes, 56.7% | 304 out of 533 genes, 57.0% | 0.5943962 |
| cellular macromolecule metabolic process | 12 out of 30 genes, 40.0% | 216 out of 533 genes, 40.5% | 0.5951692 |
| response to chemical stimulus | 4 out of 30 genes, 13.3% | 72 out of 533 genes, 13.5% | 0.5970644 |
| regulation of cell death | 2 out of 30 genes, 6.7% | 35 out of 533 genes, 6.6% | 0.6023106 |
| vesicle-mediated transport | 2 out of 30 genes, 6.7% | 35 out of 533 genes, 6.6% | 0.6023106 |
| regulation of protein modification process | 2 out of 30 genes, 6.7% | 35 out of 533 genes, 6.6% | 0.6023106 |
| regulation of apoptotic process | 2 out of 30 genes, 6.7% | 35 out of 533 genes, 6.6% | 0.6023106 |
| regulation of programmed cell death | 2 out of 30 genes, 6.7% | 35 out of 533 genes, 6.6% | 0.6023106 |
| carbohydrate derivative catabolic process | 2 out of 30 genes, 6.7% | 35 out of 533 genes, 6.6% | 0.6023106 |
| multi-organism process | 3 out of 30 genes, 10.0% | 54 out of 533 genes, 10.1% | 0.6042341 |
| protein localization to organelle | 2 out of 30 genes, 6.7% | 36 out of 533 genes, 6.8% | 0.6183189 |
| regulation of transport | 2 out of 30 genes, 6.7% | 36 out of 533 genes, 6.8% | 0.6183189 |
| positive regulation of protein metabolic process | 2 out of 30 genes, 6.7% | 36 out of 533 genes, 6.8% | 0.6183189 |
| viral reproductive process | 2 out of 30 genes, 6.7% | 37 out of 533 genes, 6.9% | 0.6338569 |
| RNA biosynthetic process | 2 out of 30 genes, 6.7% | 37 out of 533 genes, 6.9% | 0.6338569 |
| positive regulation of response to stimulus | 2 out of 30 genes, 6.7% | 37 out of 533 genes, 6.9% | 0.6338569 |
| single-organism metabolic process | 6 out of 30 genes, 20.0% | 113 out of 533 genes, 21.2% | 0.6405826 |
| regulation of primary metabolic process | 8 out of 30 genes, 26.7% | 150 out of 533 genes, 28.1% | 0.6441108 |
| small molecule metabolic process | 5 out of 30 genes, 16.7% | 95 out of 533 genes, 17.8% | 0.645856 |
| transport | 7 out of 30 genes, 23.3% | 132 out of 533 genes, 24.8% | 0.6463732 |
| multi-organism reproductive process | 2 out of 30 genes, 6.7% | 38 out of 533 genes, 7.1% | 0.648925 |
| nucleic acid metabolic process | 6 out of 30 genes, 20.0% | 114 out of 533 genes, 21.4% | 0.6501133 |
| cellular aromatic compound metabolic process | 9 out of 30 genes, 30.0% | 169 out of 533 genes, 31.7% | 0.6513993 |
| organic substance metabolic process | 17 out of 30 genes, 56.7% | 311 out of 533 genes, 58.3% | 0.651851 |
| establishment of localization | 7 out of 30 genes, 23.3% | 133 out of 533 genes, 25.0% | 0.6553674 |
| regulation of signal transduction | 3 out of 30 genes, 10.0% | 58 out of 533 genes, 10.9% | 0.6554439 |
| aromatic compound biosynthetic process | 3 out of 30 genes, 10.0% | 58 out of 533 genes, 10.9% | 0.6554439 |
| protein targeting | 2 out of 30 genes, 6.7% | 39 out of 533 genes, 7.3% | 0.663525 |
| purine nucleoside triphosphate metabolic process | 2 out of 30 genes, 6.7% | 39 out of 533 genes, 7.3% | 0.663525 |
| purine ribonucleoside triphosphate metabolic process | 2 out of 30 genes, 6.7% | 39 out of 533 genes, 7.3% | 0.663525 |
| positive regulation of biological process | 6 out of 30 genes, 20.0% | 116 out of 533 genes, 21.8% | 0.6687701 |
| cell cycle | 2 out of 30 genes, 6.7% | 40 out of 533 genes, 7.5% | 0.6776598 |
| ribonucleoside triphosphate metabolic process | 2 out of 30 genes, 6.7% | 40 out of 533 genes, 7.5% | 0.6776598 |
| purine nucleoside metabolic process | 2 out of 30 genes, 6.7% | 40 out of 533 genes, 7.5% | 0.6776598 |
| purine ribonucleoside metabolic process | 2 out of 30 genes, 6.7% | 40 out of 533 genes, 7.5% | 0.6776598 |
| organonitrogen compound catabolic process | 2 out of 30 genes, 6.7% | 40 out of 533 genes, 7.5% | 0.6776598 |
| cellular metabolic process | 16 out of 30 genes, 53.3% | 297 out of 533 genes, 55.7% | 0.6788698 |
| regulation of protein metabolic process | 3 out of 30 genes, 10.0% | 61 out of 533 genes, 11.4% | 0.6908571 |
| nucleoside triphosphate metabolic process | 2 out of 30 genes, 6.7% | 41 out of 533 genes, 7.7% | 0.6913338 |
| organic cyclic compound biosynthetic process | 3 out of 30 genes, 10.0% | 62 out of 533 genes, 11.6% | 0.7020813 |
| ribonucleoside metabolic process | 2 out of 30 genes, 6.7% | 42 out of 533 genes, 7.9% | 0.7045519 |
| organic cyclic compound metabolic process | 9 out of 30 genes, 30.0% | 176 out of 533 genes, 33.0% | 0.7077022 |
| macromolecule catabolic process | 3 out of 30 genes, 10.0% | 63 out of 533 genes, 11.8% | 0.7130147 |
| regulation of biological process | 14 out of 30 genes, 46.7% | 267 out of 533 genes, 50.1% | 0.7168278 |
| purine nucleotide metabolic process | 2 out of 30 genes, 6.7% | 43 out of 533 genes, 8.1% | 0.7173203 |
| nucleoside metabolic process | 2 out of 30 genes, 6.7% | 43 out of 533 genes, 8.1% | 0.7173203 |
| purine ribonucleotide metabolic process | 2 out of 30 genes, 6.7% | 43 out of 533 genes, 8.1% | 0.7173203 |
| purine-containing compound metabolic process | 2 out of 30 genes, 6.7% | 43 out of 533 genes, 8.1% | 0.7173203 |
| glycosyl compound metabolic process | 2 out of 30 genes, 6.7% | 43 out of 533 genes, 8.1% | 0.7173203 |
| metabolic process | 17 out of 30 genes, 56.7% | 321 out of 533 genes, 60.2% | 0.7285652 |
| ribonucleotide metabolic process | 2 out of 30 genes, 6.7% | 44 out of 533 genes, 8.3% | 0.7296456 |
| ribose phosphate metabolic process | 2 out of 30 genes, 6.7% | 44 out of 533 genes, 8.3% | 0.7296456 |
| cellular catabolic process | 5 out of 30 genes, 16.7% | 104 out of 533 genes, 19.5% | 0.7304687 |
| regulation of cell communication | 3 out of 30 genes, 10.0% | 66 out of 533 genes, 12.4% | 0.7440784 |
| nitrogen compound metabolic process | 9 out of 30 genes, 30.0% | 181 out of 533 genes, 34.0% | 0.7447196 |
| negative regulation of cellular metabolic process | 2 out of 30 genes, 6.7% | 46 out of 533 genes, 8.6% | 0.7529979 |
| regulation of signaling | 3 out of 30 genes, 10.0% | 67 out of 533 genes, 12.6% | 0.7538592 |
| RNA metabolic process | 4 out of 30 genes, 13.3% | 88 out of 533 genes, 16.5% | 0.7611799 |
| nucleobase-containing compound metabolic process | 8 out of 30 genes, 26.7% | 165 out of 533 genes, 31.0% | 0.7624758 |
| regulation of metabolic process | 8 out of 30 genes, 26.7% | 166 out of 533 genes, 31.1% | 0.7693939 |
| organonitrogen compound metabolic process | 3 out of 30 genes, 10.0% | 69 out of 533 genes, 12.9% | 0.7725741 |
| cellular response to chemical stimulus | 2 out of 30 genes, 6.7% | 48 out of 533 genes, 9.0% | 0.7746747 |
| organic substance catabolic process | 5 out of 30 genes, 16.7% | 111 out of 533 genes, 20.8% | 0.78635 |
| regulation of response to stimulus | 3 out of 30 genes, 10.0% | 71 out of 533 genes, 13.3% | 0.7901804 |
| cytoplasmic transport | 2 out of 30 genes, 6.7% | 50 out of 533 genes, 9.4% | 0.794749 |
| heterocycle metabolic process | 8 out of 30 genes, 26.7% | 170 out of 533 genes, 31.9% | 0.7957776 |
| protein transport | 3 out of 30 genes, 10.0% | 72 out of 533 genes, 13.5% | 0.7985767 |
| nucleoside phosphate metabolic process | 2 out of 30 genes, 6.7% | 51 out of 533 genes, 9.6% | 0.8042092 |
| intracellular protein transport | 2 out of 30 genes, 6.7% | 51 out of 533 genes, 9.6% | 0.8042092 |
| nucleotide metabolic process | 2 out of 30 genes, 6.7% | 51 out of 533 genes, 9.6% | 0.8042092 |
| regulation of cellular protein metabolic process | 2 out of 30 genes, 6.7% | 51 out of 533 genes, 9.6% | 0.8042092 |
| carbohydrate derivative metabolic process | 2 out of 30 genes, 6.7% | 51 out of 533 genes, 9.6% | 0.8042092 |
| establishment of protein localization | 3 out of 30 genes, 10.0% | 73 out of 533 genes, 13.7% | 0.8067072 |
| catabolic process | 5 out of 30 genes, 16.7% | 115 out of 533 genes, 21.6% | 0.8143369 |
| cellular nitrogen compound metabolic process | 8 out of 30 genes, 26.7% | 174 out of 533 genes, 32.6% | 0.8200882 |
| response to organic substance | 2 out of 30 genes, 6.7% | 53 out of 533 genes, 9.9% | 0.8220258 |
| organophosphate metabolic process | 2 out of 30 genes, 6.7% | 53 out of 533 genes, 9.9% | 0.8220258 |
| positive regulation of metabolic process | 3 out of 30 genes, 10.0% | 75 out of 533 genes, 14.1% | 0.8221876 |
| response to stimulus | 8 out of 30 genes, 26.7% | 175 out of 533 genes, 32.8% | 0.8258425 |
| regulation of cellular process | 12 out of 30 genes, 40.0% | 249 out of 533 genes, 46.7% | 0.8280852 |
| nucleobase-containing compound biosynthetic process | 2 out of 30 genes, 6.7% | 55 out of 533 genes, 10.3% | 0.8384382 |
| nucleobase-containing small molecule metabolic process | 2 out of 30 genes, 6.7% | 55 out of 533 genes, 10.3% | 0.8384382 |
| cell surface receptor signaling pathway | 2 out of 30 genes, 6.7% | 56 out of 533 genes, 10.5% | 0.8461433 |
| heterocycle biosynthetic process | 2 out of 30 genes, 6.7% | 59 out of 533 genes, 11.1% | 0.8673767 |
| cellular macromolecule catabolic process | 2 out of 30 genes, 6.7% | 59 out of 533 genes, 11.1% | 0.8673767 |
| cellular nitrogen compound biosynthetic process | 2 out of 30 genes, 6.7% | 59 out of 533 genes, 11.1% | 0.8673767 |
| cellular protein localization | 2 out of 30 genes, 6.7% | 60 out of 533 genes, 11.3% | 0.8738606 |
| cellular macromolecule localization | 2 out of 30 genes, 6.7% | 60 out of 533 genes, 11.3% | 0.8738606 |
| protein localization | 3 out of 30 genes, 10.0% | 84 out of 533 genes, 15.8% | 0.8799357 |
| organic substance transport | 3 out of 30 genes, 10.0% | 84 out of 533 genes, 15.8% | 0.8799357 |
| regulation of cellular metabolic process | 6 out of 30 genes, 20.0% | 148 out of 533 genes, 27.8% | 0.8854491 |
| mRNA metabolic process | 2 out of 30 genes, 6.7% | 66 out of 533 genes, 12.4% | 0.9072085 |
| cellular localization | 3 out of 30 genes, 10.0% | 91 out of 533 genes, 17.1% | 0.9131449 |
| positive regulation of cellular metabolic process | 2 out of 30 genes, 6.7% | 69 out of 533 genes, 12.9% | 0.9207232 |
| macromolecule localization | 3 out of 30 genes, 10.0% | 94 out of 533 genes, 17.6% | 0.9247526 |
| positive regulation of macromolecule metabolic process | 2 out of 30 genes, 6.7% | 70 out of 533 genes, 13.1% | 0.9248176 |
| signal transduction | 3 out of 30 genes, 10.0% | 99 out of 533 genes, 18.6% | 0.9411134 |
| phosphorus metabolic process | 2 out of 30 genes, 6.7% | 75 out of 533 genes, 14.1% | 0.9425626 |
| phosphate-containing compound metabolic process | 2 out of 30 genes, 6.7% | 75 out of 533 genes, 14.1% | 0.9425626 |
| regulation of macromolecule metabolic process | 5 out of 30 genes, 16.7% | 146 out of 533 genes, 27.4% | 0.9477543 |
| intracellular transport | 2 out of 30 genes, 6.7% | 78 out of 533 genes, 14.6% | 0.9512856 |
| signaling | 3 out of 30 genes, 10.0% | 103 out of 533 genes, 19.3% | 0.9518592 |
| single organism signaling | 3 out of 30 genes, 10.0% | 103 out of 533 genes, 19.3% | 0.9518592 |
| cell communication | 3 out of 30 genes, 10.0% | 107 out of 533 genes, 20.1% | 0.960827 |
| establishment of localization in cell | 2 out of 30 genes, 6.7% | 82 out of 533 genes, 15.4% | 0.9610328 |
| cellular response to stimulus | 4 out of 30 genes, 13.3% | 133 out of 533 genes, 25.0% | 0.9659531 |
| regulation of nucleobase-containing compound metabolic process | 3 out of 30 genes, 10.0% | 111 out of 533 genes, 20.8% | 0.9682702 |
| regulation of nitrogen compound metabolic process | 3 out of 30 genes, 10.0% | 115 out of 533 genes, 21.6% | 0.9744152 |
| regulation of gene expression | 3 out of 30 genes, 10.0% | 116 out of 533 genes, 21.8% | 0.9757726 |
| regulation of RNA metabolic process | 2 out of 30 genes, 6.7% | 92 out of 533 genes, 17.3% | 0.9780883 |
| regulation of biosynthetic process | 2 out of 30 genes, 6.7% | 108 out of 533 genes, 20.3% | 0.9917057 |
| Gene Ontology term | Genes annotated to the term |
|---|
| cellular component organization or biogenesis | ENSAPLP00000008674, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000013972, ENSAPLP00000006049, ENSAPLP00000004998, ENSAPLP00000011000, ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000011602, ENSAPLP00000000447, ENSAPLP00000014479, ENSAPLP00000003219 |
| cellular component organization | ENSAPLP00000008674, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000013972, ENSAPLP00000006049, ENSAPLP00000004998, ENSAPLP00000011000, ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000011602, ENSAPLP00000000447, ENSAPLP00000014479, ENSAPLP00000003219 |
| cellular component movement | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000011602, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000008674, ENSAPLP00000015503 |
| myofibril assembly | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| actomyosin structure organization | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| ribosomal small subunit biogenesis | ENSAPLP00000003372, ENSAPLP00000015662, ENSAPLP00000015793 |
| regulation of biological quality | ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000010033, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000004998 |
| regulation of actin filament polymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| regulation of actin polymerization or depolymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| regulation of actin filament length | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| regulation of protein polymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| muscle cell development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| striated muscle cell development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| regulation of actin cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| regulation of actin filament-based process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| negative regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| negative regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| erythrocyte homeostasis | ENSAPLP00000010033, ENSAPLP00000003372, ENSAPLP00000015662 |
| actin filament capping | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| regulation of cellular component size | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| striated muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| ruffle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| sarcomere organization | ENSAPLP00000009880, ENSAPLP00000003219 |
| cardiac muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| regulation of anatomical structure size | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| homeostatic process | ENSAPLP00000010033, ENSAPLP00000015679, ENSAPLP00000003372, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000015662 |
| cellular component assembly involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| negative regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| negative regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| striated muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| negative regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| cellular component biogenesis | ENSAPLP00000003372, ENSAPLP00000008674, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000015503, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000011602, ENSAPLP00000014479 |
| regulation of protein complex assembly | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| negative regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| negative regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| homeostasis of number of cells | ENSAPLP00000010033, ENSAPLP00000003372, ENSAPLP00000015662 |
| negative regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| regulation of heart contraction | ENSAPLP00000003219, ENSAPLP00000012915 |
| fertilization | ENSAPLP00000011900, ENSAPLP00000011529 |
| muscle filament sliding | ENSAPLP00000003657, ENSAPLP00000003219 |
| erythrocyte differentiation | ENSAPLP00000010033, ENSAPLP00000015662 |
| muscle organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219 |
| cardiac muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219 |
| cardiac muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219 |
| muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219 |
| cell motility | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000008674, ENSAPLP00000015503 |
| regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| localization of cell | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000008674, ENSAPLP00000015503 |
| cellular component morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| negative regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| cell junction organization | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000008674 |
| muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| regulation of cellular component biogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| cell projection organization | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| cellular developmental process | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000015503, ENSAPLP00000004998 |
| cellular component assembly | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003372, ENSAPLP00000011602, ENSAPLP00000014479, ENSAPLP00000008674, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503 |
| single-organism cellular process | ENSAPLP00000013787, ENSAPLP00000008674, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000004998, ENSAPLP00000003657, ENSAPLP00000011000, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000011602, ENSAPLP00000000447, ENSAPLP00000014479, ENSAPLP00000003219 |
| single-organism process | ENSAPLP00000013787, ENSAPLP00000008674, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000004998, ENSAPLP00000003657, ENSAPLP00000011000, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000011602, ENSAPLP00000000447, ENSAPLP00000011900, ENSAPLP00000014479, ENSAPLP00000003219 |
| locomotion | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000008674, ENSAPLP00000015503 |
| heart morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219 |
| circulatory system process | ENSAPLP00000003657, ENSAPLP00000003219 |
| heart process | ENSAPLP00000003657, ENSAPLP00000003219 |
| blood circulation | ENSAPLP00000003657, ENSAPLP00000003219 |
| actin-myosin filament sliding | ENSAPLP00000003657, ENSAPLP00000003219 |
| positive regulation of lymphocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| heart contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| actin-mediated cell contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| system development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000015503 |
| actin filament-based process | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000004998 |
| rRNA processing | ENSAPLP00000003372, ENSAPLP00000015662, ENSAPLP00000015793 |
| rRNA metabolic process | ENSAPLP00000003372, ENSAPLP00000015662, ENSAPLP00000015793 |
| muscle structure development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| organ development | ENSAPLP00000003657, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662 |
| organelle organization | ENSAPLP00000003657, ENSAPLP00000011000, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000015503, ENSAPLP00000009880, ENSAPLP00000000447, ENSAPLP00000003219 |
| positive regulation of leukocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| muscle system process | ENSAPLP00000003657, ENSAPLP00000003219 |
| 'de novo' protein folding | ENSAPLP00000009880, ENSAPLP00000015503 |
| muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| striated muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219 |
| myeloid cell differentiation | ENSAPLP00000010033, ENSAPLP00000015662 |
| positive regulation of cell activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| 'de novo' posttranslational protein folding | ENSAPLP00000009880, ENSAPLP00000015503 |
| positive regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219 |
| cell differentiation | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000015503 |
| regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000003219 |
| response to wounding | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000005038 |
| immune system development | ENSAPLP00000010033, ENSAPLP00000015662 |
| muscle organ development | ENSAPLP00000003657, ENSAPLP00000003219 |
| actin filament-based movement | ENSAPLP00000003657, ENSAPLP00000003219 |
| hemopoiesis | ENSAPLP00000010033, ENSAPLP00000015662 |
| cell-substrate adhesion | ENSAPLP00000003050, ENSAPLP00000013787 |
| cell-cell junction organization | ENSAPLP00000009880, ENSAPLP00000003050 |
| hematopoietic or lymphoid organ development | ENSAPLP00000010033, ENSAPLP00000015662 |
| anatomical structure development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000015503, ENSAPLP00000004998 |
| cell migration | ENSAPLP00000003050, ENSAPLP00000008674, ENSAPLP00000015503 |
| actin cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| regulation of cell migration | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219 |
| ncRNA processing | ENSAPLP00000003372, ENSAPLP00000015662, ENSAPLP00000015793 |
| regulation of locomotion | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219 |
| wound healing | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of cell motility | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219 |
| regulation of developmental process | ENSAPLP00000003050, ENSAPLP00000014479, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000005038 |
| inflammatory response | ENSAPLP00000003050, ENSAPLP00000005038 |
| response to metal ion | ENSAPLP00000003657, ENSAPLP00000009880 |
| regulation of lipid metabolic process | ENSAPLP00000003050, ENSAPLP00000011529 |
| cell junction assembly | ENSAPLP00000009880, ENSAPLP00000008674 |
| regulation of lymphocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| protein polymerization | ENSAPLP00000011602, ENSAPLP00000015503 |
| regulation of cellular component movement | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219 |
| anatomical structure morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| single-organism developmental process | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000004998 |
| tissue development | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of leukocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| regulation of cell activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| cell development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219 |
| macromolecular complex subunit organization | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015793, ENSAPLP00000015503, ENSAPLP00000011602 |
| protein folding | ENSAPLP00000009880, ENSAPLP00000004942, ENSAPLP00000015503 |
| ribosome biogenesis | ENSAPLP00000003372, ENSAPLP00000015662, ENSAPLP00000015793 |
| cellular macromolecular complex assembly | ENSAPLP00000003372, ENSAPLP00000011602, ENSAPLP00000001720, ENSAPLP00000015503 |
| heart development | ENSAPLP00000003657, ENSAPLP00000003219 |
| cell projection assembly | ENSAPLP00000003050, ENSAPLP00000014479 |
| cellular protein complex assembly | ENSAPLP00000011602, ENSAPLP00000015503 |
| tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219 |
| multicellular organismal development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000015503 |
| cell part morphogenesis | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000004998 |
| anatomical structure formation involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| cell projection morphogenesis | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000004998 |
| DNA packaging | ENSAPLP00000012216, ENSAPLP00000001720 |
| positive regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| response to abiotic stimulus | ENSAPLP00000003657, ENSAPLP00000003050, ENSAPLP00000000447 |
| ncRNA metabolic process | ENSAPLP00000003372, ENSAPLP00000015662, ENSAPLP00000015793 |
| protein complex subunit organization | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000011602, ENSAPLP00000005038, ENSAPLP00000015793, ENSAPLP00000015503 |
| cell morphogenesis | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000004998 |
| neuron differentiation | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000015503 |
| regulation of cytokine production | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of immune system process | ENSAPLP00000003050, ENSAPLP00000005038 |
| sexual reproduction | ENSAPLP00000011900, ENSAPLP00000011529 |
| extracellular matrix organization | ENSAPLP00000013972, ENSAPLP00000006049 |
| extracellular structure organization | ENSAPLP00000013972, ENSAPLP00000006049 |
| DNA conformation change | ENSAPLP00000012216, ENSAPLP00000001720 |
| regulation of multicellular organismal process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000012915 |
| developmental process | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000015503, ENSAPLP00000004998 |
| macromolecular complex assembly | ENSAPLP00000003372, ENSAPLP00000011602, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503 |
| blood coagulation | ENSAPLP00000009880, ENSAPLP00000003050 |
| hemostasis | ENSAPLP00000009880, ENSAPLP00000003050 |
| response to inorganic substance | ENSAPLP00000003657, ENSAPLP00000009880 |
| coagulation | ENSAPLP00000009880, ENSAPLP00000003050 |
| cellular process | ENSAPLP00000013787, ENSAPLP00000014148, ENSAPLP00000008674, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000012915, ENSAPLP00000004998, ENSAPLP00000003657, ENSAPLP00000009730, ENSAPLP00000011000, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000011602, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000014479 |
| response to external stimulus | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003050 |
| translation | ENSAPLP00000010033, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000015793 |
| immune system process | ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000015662 |
| regulation of localization | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005038 |
| translational elongation | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000015793 |
| ribonucleoprotein complex biogenesis | ENSAPLP00000003372, ENSAPLP00000015662, ENSAPLP00000015793 |
| microtubule-based movement | ENSAPLP00000011602, ENSAPLP00000015503 |
| single organism reproductive process | ENSAPLP00000011900, ENSAPLP00000011529 |
| negative regulation of cellular process | ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000012296, ENSAPLP00000004998 |
| regulation of immune system process | ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| axon guidance | ENSAPLP00000009880, ENSAPLP00000003050 |
| cellular lipid metabolic process | ENSAPLP00000011529, ENSAPLP00000005038 |
| small molecule biosynthetic process | ENSAPLP00000005038, ENSAPLP00000012915 |
| regulation of body fluid levels | ENSAPLP00000009880, ENSAPLP00000003050 |
| negative regulation of developmental process | ENSAPLP00000001720, ENSAPLP00000005038 |
| cardiovascular system development | ENSAPLP00000003657, ENSAPLP00000003219 |
| circulatory system development | ENSAPLP00000003657, ENSAPLP00000003219 |
| reproduction | ENSAPLP00000008212, ENSAPLP00000000447, ENSAPLP00000011900, ENSAPLP00000011529, ENSAPLP00000015793 |
| neurogenesis | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000015503 |
| generation of neurons | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000015503 |
| chromosome organization | ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000001720 |
| organic substance biosynthetic process | ENSAPLP00000009730, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000005038, ENSAPLP00000015793, ENSAPLP00000010033, ENSAPLP00000011529, ENSAPLP00000012915 |
| regulation of phosphate metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005038 |
| regulation of phosphorus metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005038 |
| cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219 |
| cellular component disassembly | ENSAPLP00000008212, ENSAPLP00000000447, ENSAPLP00000015793 |
| regulation of phosphorylation | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000005038 |
| M phase | ENSAPLP00000000447, ENSAPLP00000015503 |
| positive regulation of kinase activity | ENSAPLP00000003050, ENSAPLP00000000447 |
| regulation of system process | ENSAPLP00000003219, ENSAPLP00000012915 |
| single-organism biosynthetic process | ENSAPLP00000005038, ENSAPLP00000012915 |
| positive regulation of transferase activity | ENSAPLP00000003050, ENSAPLP00000000447 |
| single-multicellular organism process | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000015503 |
| biosynthetic process | ENSAPLP00000009730, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000005038, ENSAPLP00000015793, ENSAPLP00000010033, ENSAPLP00000011529, ENSAPLP00000012915 |
| organic acid metabolic process | ENSAPLP00000009730, ENSAPLP00000005038, ENSAPLP00000012915 |
| protein complex assembly | ENSAPLP00000011602, ENSAPLP00000005038, ENSAPLP00000015503 |
| carboxylic acid metabolic process | ENSAPLP00000009730, ENSAPLP00000005038, ENSAPLP00000012915 |
| oxoacid metabolic process | ENSAPLP00000009730, ENSAPLP00000005038, ENSAPLP00000012915 |
| defense response | ENSAPLP00000003050, ENSAPLP00000005038 |
| axonogenesis | ENSAPLP00000009880, ENSAPLP00000003050 |
| embryo development | ENSAPLP00000003050, ENSAPLP00000003219 |
| chromatin modification | ENSAPLP00000012216, ENSAPLP00000001720 |
| regulation of anatomical structure morphogenesis | ENSAPLP00000003050, ENSAPLP00000014479 |
| neuron projection development | ENSAPLP00000009880, ENSAPLP00000003050 |
| cell morphogenesis involved in neuron differentiation | ENSAPLP00000009880, ENSAPLP00000003050 |
| neuron projection morphogenesis | ENSAPLP00000009880, ENSAPLP00000003050 |
| cell adhesion | ENSAPLP00000003050, ENSAPLP00000013787, ENSAPLP00000006049 |
| biological adhesion | ENSAPLP00000003050, ENSAPLP00000013787, ENSAPLP00000006049 |
| protein complex biogenesis | ENSAPLP00000011602, ENSAPLP00000005038, ENSAPLP00000015503 |
| negative regulation of biological process | ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000012296, ENSAPLP00000004998 |
| response to stress | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005038, ENSAPLP00000004942 |
| chemotaxis | ENSAPLP00000009880, ENSAPLP00000003050 |
| taxis | ENSAPLP00000009880, ENSAPLP00000003050 |
| chemical homeostasis | ENSAPLP00000015679, ENSAPLP00000011529 |
| biological regulation | ENSAPLP00000015662, ENSAPLP00000012296, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000012915, ENSAPLP00000004998, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000014479, ENSAPLP00000003219 |
| regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000004998 |
| multicellular organismal process | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000015503 |
| cellular process involved in reproduction | ENSAPLP00000008212, ENSAPLP00000000447, ENSAPLP00000015793 |
| cell morphogenesis involved in differentiation | ENSAPLP00000009880, ENSAPLP00000003050 |
| positive regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| macromolecule biosynthetic process | ENSAPLP00000010033, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000011529, ENSAPLP00000015793 |
| cellular macromolecule biosynthetic process | ENSAPLP00000010033, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000011529, ENSAPLP00000015793 |
| positive regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038 |
| neuron development | ENSAPLP00000009880, ENSAPLP00000003050 |
| positive regulation of catalytic activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219 |
| cellular biosynthetic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000005038, ENSAPLP00000015793, ENSAPLP00000010033, ENSAPLP00000011529, ENSAPLP00000012915 |
| reproductive process | ENSAPLP00000008212, ENSAPLP00000011900, ENSAPLP00000011529, ENSAPLP00000015793 |
| system process | ENSAPLP00000003657, ENSAPLP00000003219 |
| cellular membrane organization | ENSAPLP00000011000, ENSAPLP00000003050 |
| positive regulation of phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038 |
| membrane organization | ENSAPLP00000011000, ENSAPLP00000003050 |
| nervous system development | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000015503 |
| translational termination | ENSAPLP00000008212, ENSAPLP00000015793 |
| lipid metabolic process | ENSAPLP00000011529, ENSAPLP00000005038 |
| microtubule-based process | ENSAPLP00000011602, ENSAPLP00000015503 |
| viral genome expression | ENSAPLP00000008212, ENSAPLP00000015793 |
| viral transcription | ENSAPLP00000008212, ENSAPLP00000015793 |
| regulation of catalytic activity | ENSAPLP00000003050, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000003219 |
| chromatin organization | ENSAPLP00000012216, ENSAPLP00000001720 |
| positive regulation of phosphorus metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| protein complex disassembly | ENSAPLP00000008212, ENSAPLP00000015793 |
| regulation of kinase activity | ENSAPLP00000003050, ENSAPLP00000000447 |
| cellular protein complex disassembly | ENSAPLP00000008212, ENSAPLP00000015793 |
| positive regulation of phosphate metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| regulation of transferase activity | ENSAPLP00000003050, ENSAPLP00000000447 |
| viral infectious cycle | ENSAPLP00000008212, ENSAPLP00000015793 |
| cell cycle phase | ENSAPLP00000000447, ENSAPLP00000015503 |
| macromolecular complex disassembly | ENSAPLP00000008212, ENSAPLP00000015793 |
| regulation of multicellular organismal development | ENSAPLP00000003050, ENSAPLP00000001720 |
| protein metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000015793, ENSAPLP00000004942, ENSAPLP00000015503, ENSAPLP00000010033, ENSAPLP00000009880, ENSAPLP00000013972, ENSAPLP00000011529 |
| mitotic cell cycle | ENSAPLP00000000447, ENSAPLP00000015503 |
| cotranslational protein targeting to membrane | ENSAPLP00000008212, ENSAPLP00000015793 |
| SRP-dependent cotranslational protein targeting to membrane | ENSAPLP00000008212, ENSAPLP00000015793 |
| protein targeting to ER | ENSAPLP00000008212, ENSAPLP00000015793 |
| regulation of cell differentiation | ENSAPLP00000011529, ENSAPLP00000001720 |
| protein localization to endoplasmic reticulum | ENSAPLP00000008212, ENSAPLP00000015793 |
| establishment of protein localization to endoplasmic reticulum | ENSAPLP00000008212, ENSAPLP00000015793 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | ENSAPLP00000008212, ENSAPLP00000015793 |
| regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038 |
| regulation of cell cycle | ENSAPLP00000000447, ENSAPLP00000005038 |
| viral reproduction | ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000015793 |
| multi-organism cellular process | ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000015793 |
| protein targeting to membrane | ENSAPLP00000008212, ENSAPLP00000015793 |
| regulation of hydrolase activity | ENSAPLP00000012216, ENSAPLP00000003219 |
| single-organism transport | ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000015662, ENSAPLP00000015793 |
| positive regulation of molecular function | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219 |
| nuclear-transcribed mRNA catabolic process | ENSAPLP00000008212, ENSAPLP00000015793 |
| negative regulation of RNA metabolic process | ENSAPLP00000010033, ENSAPLP00000012296 |
| establishment of protein localization to organelle | ENSAPLP00000008212, ENSAPLP00000015793 |
| regulation of response to stress | ENSAPLP00000003050, ENSAPLP00000005038 |
| response to oxygen-containing compound | ENSAPLP00000003657, ENSAPLP00000003219 |
| localization | ENSAPLP00000008212, ENSAPLP00000008674, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000015503, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000004998 |
| RNA catabolic process | ENSAPLP00000008212, ENSAPLP00000015793 |
| mRNA catabolic process | ENSAPLP00000008212, ENSAPLP00000015793 |
| translational initiation | ENSAPLP00000008212, ENSAPLP00000015793 |
| positive regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000005038 |
| negative regulation of nucleobase-containing compound metabolic process | ENSAPLP00000010033, ENSAPLP00000012296 |
| negative regulation of nitrogen compound metabolic process | ENSAPLP00000010033, ENSAPLP00000012296 |
| nucleobase-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000015793, ENSAPLP00000015503 |
| regulation of molecular function | ENSAPLP00000003050, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000003219 |
| RNA processing | ENSAPLP00000003372, ENSAPLP00000015662, ENSAPLP00000015793 |
| aromatic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000015793, ENSAPLP00000015503 |
| positive regulation of signal transduction | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of cell communication | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of signaling | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| macromolecule metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000014148, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000004942, ENSAPLP00000015503, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000013972, ENSAPLP00000011529 |
| purine nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| purine nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| purine ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| negative regulation of gene expression | ENSAPLP00000010033, ENSAPLP00000005038 |
| cell cycle process | ENSAPLP00000000447, ENSAPLP00000015503 |
| ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| purine ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| glycosyl compound catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| positive regulation of cellular process | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005038 |
| cellular nitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000015793, ENSAPLP00000015503 |
| heterocycle catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000015793, ENSAPLP00000015503 |
| organic cyclic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000015793, ENSAPLP00000015503 |
| negative regulation of macromolecule metabolic process | ENSAPLP00000010033, ENSAPLP00000005038, ENSAPLP00000012296 |
| cellular protein metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000015793, ENSAPLP00000004942, ENSAPLP00000015503, ENSAPLP00000010033, ENSAPLP00000009880 |
| gene expression | ENSAPLP00000010033, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000015662, ENSAPLP00000015793 |
| purine nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| DNA metabolic process | ENSAPLP00000012216, ENSAPLP00000001720 |
| purine ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| organophosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| purine-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| nucleoside phosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| negative regulation of metabolic process | ENSAPLP00000010033, ENSAPLP00000005038, ENSAPLP00000012296 |
| primary metabolic process | ENSAPLP00000014148, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000012915, ENSAPLP00000009730, ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503 |
| cellular macromolecule metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000014148, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000004942, ENSAPLP00000015503, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000011529 |
| response to chemical stimulus | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of cell death | ENSAPLP00000013972, ENSAPLP00000005038 |
| vesicle-mediated transport | ENSAPLP00000003050, ENSAPLP00000004998 |
| regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000005038 |
| regulation of apoptotic process | ENSAPLP00000013972, ENSAPLP00000005038 |
| regulation of programmed cell death | ENSAPLP00000013972, ENSAPLP00000005038 |
| carbohydrate derivative catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| multi-organism process | ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000015793 |
| protein localization to organelle | ENSAPLP00000008212, ENSAPLP00000015793 |
| regulation of transport | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of protein metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| viral reproductive process | ENSAPLP00000008212, ENSAPLP00000015793 |
| RNA biosynthetic process | ENSAPLP00000008212, ENSAPLP00000015793 |
| positive regulation of response to stimulus | ENSAPLP00000003050, ENSAPLP00000005038 |
| single-organism metabolic process | ENSAPLP00000003657, ENSAPLP00000009730, ENSAPLP00000011529, ENSAPLP00000005038, ENSAPLP00000012915, ENSAPLP00000015503 |
| regulation of primary metabolic process | ENSAPLP00000012216, ENSAPLP00000005038, ENSAPLP00000012296, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000011529 |
| small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000009730, ENSAPLP00000005038, ENSAPLP00000012915, ENSAPLP00000015503 |
| transport | ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000004998 |
| multi-organism reproductive process | ENSAPLP00000008212, ENSAPLP00000015793 |
| nucleic acid metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000015793 |
| cellular aromatic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000015503, ENSAPLP00000012915 |
| organic substance metabolic process | ENSAPLP00000014148, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000012915, ENSAPLP00000009730, ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503 |
| establishment of localization | ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000004998 |
| regulation of signal transduction | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006049 |
| aromatic compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000012915, ENSAPLP00000015793 |
| protein targeting | ENSAPLP00000008212, ENSAPLP00000015793 |
| purine nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| purine ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| positive regulation of biological process | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005038 |
| cell cycle | ENSAPLP00000000447, ENSAPLP00000015503 |
| ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| purine nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| purine ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| organonitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| cellular metabolic process | ENSAPLP00000014148, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000011529, ENSAPLP00000012915, ENSAPLP00000009730, ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000008212, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503 |
| regulation of protein metabolic process | ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000005038 |
| nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| organic cyclic compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000012915, ENSAPLP00000015793 |
| ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| organic cyclic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000015503, ENSAPLP00000012915 |
| macromolecule catabolic process | ENSAPLP00000008212, ENSAPLP00000011529, ENSAPLP00000015793 |
| regulation of biological process | ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000012296, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000014479, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000012915, ENSAPLP00000004998 |
| purine nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| purine ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| purine-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| glycosyl compound metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| metabolic process | ENSAPLP00000014148, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000010033, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000012915, ENSAPLP00000009730, ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015503 |
| ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| ribose phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| cellular catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000011529, ENSAPLP00000015793, ENSAPLP00000015503 |
| regulation of cell communication | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006049 |
| nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000015503, ENSAPLP00000012915 |
| negative regulation of cellular metabolic process | ENSAPLP00000010033, ENSAPLP00000012296 |
| regulation of signaling | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006049 |
| RNA metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000015662, ENSAPLP00000015793 |
| nucleobase-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000015503 |
| regulation of metabolic process | ENSAPLP00000012216, ENSAPLP00000005038, ENSAPLP00000012296, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000011529 |
| organonitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000012915, ENSAPLP00000015503 |
| cellular response to chemical stimulus | ENSAPLP00000003050, ENSAPLP00000003219 |
| organic substance catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000011529, ENSAPLP00000015793, ENSAPLP00000015503 |
| regulation of response to stimulus | ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000006049 |
| cytoplasmic transport | ENSAPLP00000008212, ENSAPLP00000015793 |
| heterocycle metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000015503 |
| protein transport | ENSAPLP00000008212, ENSAPLP00000011529, ENSAPLP00000015793 |
| nucleoside phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| intracellular protein transport | ENSAPLP00000008212, ENSAPLP00000015793 |
| nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| carbohydrate derivative metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| establishment of protein localization | ENSAPLP00000008212, ENSAPLP00000011529, ENSAPLP00000015793 |
| catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000011529, ENSAPLP00000015793, ENSAPLP00000015503 |
| cellular nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000015793, ENSAPLP00000015503 |
| response to organic substance | ENSAPLP00000003657, ENSAPLP00000003050 |
| organophosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| positive regulation of metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000005038 |
| response to stimulus | ENSAPLP00000003657, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447 |
| regulation of cellular process | ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000012296, ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000000447, ENSAPLP00000014479, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000006049, ENSAPLP00000004998 |
| nucleobase-containing compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000015793 |
| nucleobase-containing small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| cell surface receptor signaling pathway | ENSAPLP00000003050, ENSAPLP00000005038 |
| heterocycle biosynthetic process | ENSAPLP00000008212, ENSAPLP00000015793 |
| cellular macromolecule catabolic process | ENSAPLP00000008212, ENSAPLP00000015793 |
| cellular nitrogen compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000015793 |
| cellular protein localization | ENSAPLP00000008212, ENSAPLP00000015793 |
| cellular macromolecule localization | ENSAPLP00000008212, ENSAPLP00000015793 |
| protein localization | ENSAPLP00000008212, ENSAPLP00000011529, ENSAPLP00000015793 |
| organic substance transport | ENSAPLP00000008212, ENSAPLP00000011529, ENSAPLP00000015793 |
| regulation of cellular metabolic process | ENSAPLP00000010033, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005038, ENSAPLP00000012296 |
| mRNA metabolic process | ENSAPLP00000008212, ENSAPLP00000015793 |
| cellular localization | ENSAPLP00000003050, ENSAPLP00000008212, ENSAPLP00000015793 |
| positive regulation of cellular metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| macromolecule localization | ENSAPLP00000008212, ENSAPLP00000011529, ENSAPLP00000015793 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| signal transduction | ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| phosphorus metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| phosphate-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000015503 |
| regulation of macromolecule metabolic process | ENSAPLP00000010033, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000012296 |
| intracellular transport | ENSAPLP00000008212, ENSAPLP00000015793 |
| signaling | ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| single organism signaling | ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| cell communication | ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| establishment of localization in cell | ENSAPLP00000008212, ENSAPLP00000015793 |
| cellular response to stimulus | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000010033, ENSAPLP00000003219, ENSAPLP00000012296 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000010033, ENSAPLP00000003219, ENSAPLP00000012296 |
| regulation of gene expression | ENSAPLP00000010033, ENSAPLP00000005038, ENSAPLP00000012296 |
| regulation of RNA metabolic process | ENSAPLP00000010033, ENSAPLP00000012296 |
| regulation of biosynthetic process | ENSAPLP00000010033, ENSAPLP00000011529 |
|